Table 3 summarizes the principal Nrf2-dependent pathways implicated in IBD-associated tumorigenesis and intestinal fibrosis, highlighting their molecular targets and clinical relevance. This evidence concerns the gene NFE2L2 and inflammatory bowel disease.